Capital FM Kenya |
First Lady champions mobile blood donation units
Capital FM Kenya Gachoka will take part in the Bank of America Chicago Marathon 2013 to raise funds for purchase of mobile blood donation units in the country. Gachoka’s initiative was sparked by numerous appeals for blood in the media. She decided to participate in … |
Teva's (TEVA) TREANDA Approved by US FDA – StreetInsider.com (subscription)
|
Teva’s (TEVA) TREANDA Approved by US FDA
StreetInsider.com (subscription) TREANDA is indicated for use in patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen, and in patients with chronic lymphocytic leukemia … |
FDA Approves Teva's TREANDA(R) (bendamustine HCI) Injection, a New Liquid … – MarketWatch
|
FDA Approves Teva’s TREANDA(R) (bendamustine HCI) Injection, a New Liquid …
MarketWatch TREANDA is indicated for use in patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen, and in patients with chronic lymphocytic leukemia … |
Halozyme Therapeutics, Inc. (HALO): Bullish On Halozyme: Short-Term … – Seeking Alpha
|
Halozyme Therapeutics, Inc. (HALO): Bullish On Halozyme: Short-Term …
Seeking Alpha The second therapy is MabThera SC, or Rituximab, with trade name Rituxan. Rituxan was approved in the US in 1997 for the treatment of non-Hodgkin’s lymphoma. With validation of the approval of the monoclonal antibody Herceptin SC, it’s looking like … |
BCM Researchers Discover Simpler, Improved Biomarkers to Predict Heart … – BioNews Texas
BioNews TexasBCM Researchers Discover Simpler, Improved Biomarkers to Predict Heart …BioNews Texasbiomarkers for heart failure Researchers at the Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs hospital discovered two improved …
Avacta Appoints New R&D Chief For Affimer Antibodies Alternative – London South East
Avacta Appoints New R&D Chief For Affimer Antibodies AlternativeLondon South EastAvacta acquired the intellectual property rights to Affimer – an alternative to the antibodies widely used in life-sciences research, diagnostics and therapeutics – in…
6 Reasons Why There's No Wrong Way to Be a Woman – Huffington Post Canada
|
6 Reasons Why There’s No Wrong Way to Be a Woman
Huffington Post Canada Do you want to live a clean and religious life? Okay. Go for it. Do you want to burn your bras and swing ….. know what I’d do, or the person I would be without her. This pic is typical of us on holiday – our cab driver in India decided that traffic … |
Three MCW Faculty to Receive Distinguished Service Awards – Wauwatosa Now
|
Three MCW Faculty to Receive Distinguished Service Awards
Wauwatosa Now Dr. Franco helped lead program development in Froedtert & the Medical College of Wisconsin’s liver transplant and hepatitis treatment programs. He has served as Director of Hepatology and Medical Director of Liver Transplantation and has participated … |
BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent … – MarketWatch (press release)
BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent …MarketWatch (press release)According to a 2011 report from Decision Resources, about 180 million people worldwide are chronically infected with HCV. In addition, HCV infectio…
Spectrum's heart-lung transplant one of just 12 in US this year; doctors … – Mlive Kalamazoo
|
Spectrum’s heart-lung transplant one of just 12 in US this year; doctors …
Mlive Kalamazoo When a donor’s heart and lungs became available, the transplant surgery was performed Aug. 23. On Saturday, Sept. 14, Sargent went home from the hospital. He said Monday night his recovery is going well. Khaghani emphasized that the transplant took a … |